Anlotinib improves bile duct ligature‐induced liver fibrosis in rats via antiangiogenesis regulated by VEGFR2/mTOR pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anlotinib improves bile duct ligature‐induced liver fibrosis in rats via antiangiogenesis regulated by VEGFR2/mTOR pathway

Published:2022-12-04 Issue:2 Volume:84 Page:143-155
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Development Research

Author:

Lei Jun¹,Li Qing²,Xu Hongyan³,Luo Ming¹,Liu Zhiwen⁴,Xiang Deng¹,Chen Peiqun¹^ORCID

Affiliation:

1. Department of General Surgery Jiangxi Provincial Children's Hospital Nanchang Jiangxi P.R. China

2. Rehabilitation Center Jiangxi Provincial Children's Hospital Nanchang Jiangxi P.R. China

3. Department of Pathology Jiangxi Provincial Children's Hospital Nanchang Jiangxi P.R. China

4. Department of neonatal surgery Jiangxi Provincial Children's Hospital Nanchang Jiangxi P.R. China

Funder

Natural Science Foundation of Jiangxi Province

Publisher

Wiley

Subject

Drug Discovery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ddr.22019

Reference30 articles.

1. mTOR signaling in cellular and organismal energetics

2. Anlotinib Inhibits PFKFB3-Driven Glycolysis in Myofibroblasts to Reverse Pulmonary Fibrosis

3. The Sea Lamprey as an Etiological Model for Biliary Atresia

4. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis

5. TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anlotinib inhibits cervical cancer cell proliferation and invasion by suppressing cytokine secretion in activated cancer-associated fibroblasts;Frontiers in Oncology;2024-08-13

2. Anlotinib Attenuates Liver Fibrosis by Regulating the Transforming Growth Factor β1/Smad3 Signaling Pathway;Digestive Diseases and Sciences;2023-09-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3